WATER, ETHYLHEXYL METHOXYCINNAMATE, BUTYLENE GLYCOL, ETHYLHEXYL SALICYLATE, OCTOCRYLENE, BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE, BUTYL METHOXYDIBENZOYLMETHANE, DIPROPYLENE GLYCOL, NIACINAMIDE, SQUALANE, C14-22 ALCOHOLS, 1,2-HEXANEDIOL, POLYGLYCERYL-2 STEARATE, PROPANEDIOL, HYDROXYACETOPHENONE, GLYCERYL STEARATE, STEARYL ALCOHOL, C12-20 ALKYL GLUCOSIDE, TROMETHAMINE, CENTELLA ASIATICA EXTRACT, CARBOMER, MELALEUCA ALTERNIFOLIA (TEA TREE) EXTRACT, HIPPOPHAE RHAMNOIDES FRUIT EXTRACT, VITIS VINIFERA (GRAPE) FRUIT EXTRACT, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, UNCARIA SINENSIS EXTRACT, GLYCERIN, ADENOSINE, DISODIUM EDTA, ORYZA SATIVA (RICE) BRAN EXTRACT, HYDROGENATED PHOSPHATIDYLCHOLINE, CAPRYLIC/CAPRIC TRIGLYCERIDE, SODIUM HYALURONATE, GLUCOSE, HYDROLYZED COLLAGEN, SUCROSE STEARATE, GLUTATHIONE, CYCLODEXTRIN, CETEARYL ALCOHOL, CAPRYLYL GLYCOL, BETA-GLUCAN, CAPRYLHYDROXAMIC ACID, ETHYLHEXYLGLYCERIN, ASIATIC ACID, ASIATICOSIDE, MADECASSIC ACID, MADECASSOSIDE, TROPOLONE, HYALURONIC ACID, POTASSIUM HYALURONATE *** Ingredients are subject to change at the manufacturer's discretion
A commenter requested that CMS rerun the cost modeling for the APCs excluding low volume or anomalous facility reports and consider volatility guards, public analysis regarding observed changes, and maintain payment levels that preserve beneficiary access until stable cost data can be established
Regulation of xCT expression and system x (c) (-) function in neuronal cells
Finasteride is the most commonly prescribed DHT blocker for hair loss and is FDA-approved for this use
F.AdamsD
